HIGHLIGHTS
- who: Thomas Brodowicz and collaborators from the Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna-General Hospital, Lille, France have published the research: Assessing Prognostic and Predictive Biomarkers of Regorafenib Response in Patients with Advanced Soft Tissue Sarcoma: REGOSARC Study, in the Journal: (JOURNAL)
- what: The analysis was based on all patients enrolled in the cohort A, B, C, or D of the REGOSARC trial, provided they had biomarkers' evaluation (n=134). The aim of this translational study analysis was to evaluate the prognostic value, and the predictive value of the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.